Synthesis of Pyrrole-2-acetic Esters and (Pyridine-2-one)-3-acetic Amides
FULL PAPERS
reduced pressure, and the product purified by column chro- References
matography (SiO2), using hexane-AcOEt, from 95:5 to 9:1,
as the eluent, to afford 2g as a yellow oil (yield: 73.1 mg,
32%).
[1] For excellent recent reviews, see: a) S. A. Vizer, K. B.
Yerzhanov, A. A. A. Al Quntar, V. M. Dembitsky, Tet-
rahedron 2004, 60, 5499–5538; b) G. Zeni, R. C.
Larock, Chem. Rev. 2004, 104, 2285–2309; c) I. Naka-
mura, Y. Yamamoto, Chem. Rev. 2004, 104, 2127–2198.
[2] B. Gabriele, G. Salerno, M. Costa, Synlett 2004, 2468–
2483.
Oxidative Methoxycarbonylation of Phenyl-(3-
methylnon-2-en-4-ynyl)amine 1 h and Separation of
Products [Eq. (11)]
A 250-mL stainless steel autoclave was charged in the pres-
ence of air with PdI2 (3.0 mg, 8.3310À3 mmol), KI
(277.8mg, 1.67 mmol) and a solution of 1h (191.0 mg,
0.84 mmol) in MeOH (16.8 mL). The autoclave was pressur-
ized at room temperature with stirring with CO2 (50 atm),
CO (up to 80 atm) and air (up to 90 atm of total pressure),
and then heated at 1008C with stirring for 2 h. After cooling,
the autoclave was degassed, the solvent evaporated under
reduced pressure, and the product purified by column chro-
matography (SiO2), using hexane-AcOEt, from 100:0 to
95:5, as the eluent, to afford 2h as a yellow oil (yield:
140.0 mg, 58%).
[3] B. Gabriele, G. Salerno, M. Costa, G. P. Chiusoli, Curr.
Org. Chem. 2004, 8, 919–946.
[4] B. Gabriele, G. Salerno, M. Costa, G. P. Chiusoli, J. Or-
ganomet. Chem. 2003, 687, 219–228.
[5] B. Gabriele, G. Salerno, F. De Pascali, M. Costa, G. P.
Chiusoli, J. Org. Chem. 1999, 64, 7693–7699.
[6] B. Gabriele, G. Salerno, A. Fazio, F. B. Campana,
Chem. Commun. 2002, 1408–1409.
[7] Several derivatives of these classes of carbonyl com-
pounds have shown interesting pharmacological activi-
ty. For representative examples, see: a) J. R. Carson, S.
Wong, J. Med. Chem. 1973, 16, 172–174; b) J. R.
Carson, (McNeil Laboratories, Inc.), Ger. Offen.
2,339,140, 1974; Chem. Abstr. 1974, 80, P133244f;
c) J. R. Carson, (McNeil Laboratories, Inc.), US Patent
4,048,191 A, 1975; Chem. Abstr. 1976, 85, P108517t;
d) M. W. Whitehouse, K. D. Rainsford, J. Pharm. Phar-
macol. 1980, 32, 795–796; e) L. J. Powers, S. W. Fogt,
Z. S. Ariyan, D. J. Rippin, R. D. Heilman, R. J. Mat-
thews, J. Med. Chem. 1981, 24, 604–609; f) J. F. Pritch-
ard, R. K. Desiraju, J. Pharm. Sci. 1982, 71, 964–965;
g) R. Zurita, (Laboratorios Rubio S. A.), Spanish
Patent 502650, 1982; Chem. Abstr. 1982, 97, P162811v;
h) J. B. Doherty, M. N. Chang, C. P. Dorn, Jr., (Merck
and Co., Inc.), European Patent 72013, 1983; Chem.
Abstr. 1983, 99, P22311y; i) J. B. Doherthy, M. N.
Chang, C. P. Dorn, US Patent 4,434,175, 1984; Chem.
Abstr. 1984, 100, P191732f; j) G. A. Youngdale, T. F.
Oglia, J. Med. Chem. 1985, 28, 1790–1796; k) J. M. Mu-
chowski, E. Galeazzi, R. Greenhouse, A. Guzmꢁn, V.
Perꢂz, N. Ackerman, S. A. Ballaron, J. R. Rovito, A. J.
Tomolosis, J. M. Young, W. H. Rooks, II, J. Med.
Chem. 1989, 32, 1202–1207; l) M. Lehr, Eur. J. Med.
Chem. Chim. Ther. 1997, 32, 805–814; m) M. Lehr, J.
Med. Chem. 1997, 40, 3381–3392; n) C. Dendrinou-
Samara, G. Tsotsou, L. V. Ekateriniadou, A. H. Kortsa-
ris, C. P. Reptopoulou, A. Terzis, D. A. Kyriakidis, D. P.
Kessissoglou, J. Inorg. Biochem. 1998, 71, 171–179;
o) S. Sortino, J. C. Scaiano, G. De Guidi, S. Monti, Pho-
tochem. Photobiol. 1999, 70, 549–556; p) O. A. Attana-
si, S. M. Colombani, L. De Crescentini, R. Giorgi, S.
Monti, A. Perrone, F. R. Perrulli, A. R. Renzetti, S.
Santeusanio, Farmaco, 1999, 54, 64–76; q) S. D. Larsen,
M. A. Connell, M. M. Cudahy, B. R. Evans, P. D. May,
M. D. Meglasson, T. J. OꢃSullivan, H. J. Schostarez, J. C.
Sih, F. C. Stevens, S. P. Tanis, C. M. Tegley, J. A. Tucker,
V. A. Vaillancourt, T. J. Vidmar, W. Watt, J. H. Yu, J.
Med. Chem. 2001, 44, 1217–1230; r) C. Anagnostou, I.
Nicolaou, V. J. Demopoulos, Pharmazie 2002, 57, 435–
437.
Oxidative Carbonylation of (3-methylnon-2-en-4-
ynyl)amine 1i in the Absence of Morpholine and
Separation of Products [Eq. (12)]
A 250-mL stainless steel autoclave was charged in the pres-
ence of air with PdI2 (5.0 mg, 1.3910À2 mmol), KI
(462.0 mg, 2.78mmol) and a solution of 1i (210.0 mg,
1.39 mmol) in MeOH (27.8mL). The autoclave was pressur-
ized at room temperature with stirring with CO2 (50 atm),
CO (up to 80 atm) and air (up to 90 atm of total pressure),
and then heated at 708C with stirring for 5 h. After cooling,
the autoclave was degassed, the solvent evaporated under
reduced pressure, and the products purified by column chro-
matography (SiO2), using hexane-AcOEt, from 9:1 to 8:2, as
the eluent, to afford 11i (yellow oil, yield: 44.1 mg, 15%)
followed by 12i (colorless solid, mp 83–848C, yield: 92.1 mg,
40%).
Oxidative Carbonylation of (3-methylnon-2-en-4-
ynyl)amine 1i in the Presence of Morpholine and
Separation of Products [Eq. (13)]
A 250-mL stainless steel autoclave was charged in the pres-
ence of air with PdI2 (5.0 mg, 1.3910À2 mmol), KI
(462.0 mg, 2.78mmol) and a solution of 1i (210.0 mg,
1.39 mmol) and morpholine (365.0 mg, 4.19 mmol) in
MeOH (27.8mL). The autoclave was pressurized at room
temperature with stirring with CO2 (50 atm), CO (up to 80
atm) and air (up to 90 atm of total pressure), and then
heated at 708C with stirring for 5 h. After cooling, the auto-
clave was degassed, the solvent evaporated under reduced
pressure, and the product purified by column chromatogra-
phy (SiO2), using hexane-AcOEt, from 8:2 to 6:4, as the
eluent, to afford 13i as a pale yellow solid, mp 59–608C
(yield: 298.5 mg, 81%).
[8] The spontaneous or metal-catalyzed cycloisomerization
of (Z)-(2-en-4-ynyl)amines was reported to be a gener-
al methodology for the synthesis of substituted pyr-
Adv. Synth. Catal. 2006, 348, 2212 – 2222
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2221